TERN
Terns Pharmaceuticals, Inc. · Healthcare
Vivo Opportunity, LLC bought $7.0M of Terns Pharmaceuticals, Inc.
10% owner
Bought$6,980,244
$2.66Price
2,624,239Shares
+63%Stake
What TERN did for a copier
- $1,000 copied at Wed, Aug 17 open, $5.02
- $1,141
- S&P 500, same days
- −14.5%
Measured over 30 trading days, to the Sep 29 close.
Vivo Opportunity, LLC's record
4 other buys with 3 months of prices since 2022: on average +20.8% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 12. Filed Tue, Aug 16, 8:44 PM ET, after the close. Returns use the Aug 17 open and the Sep 29 close. Not investment advice.